Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amgen Inc.    AMGN

AMGEN INC.

(AMGN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
224.89(c) 223.46(c) 216.38(c) 217.82(c) 216.94(c) Last
3 087 094 1 934 371 2 873 957 2 994 097 3 251 427 Volume
-1.00% -0.64% -3.17% +0.67% -0.40% Change
More quotes
Financials (USD)
Sales 2020 25 293 M - -
Net income 2020 7 048 M - -
Net Debt 2020 20 405 M - -
P/E ratio 2020 18,3x
Yield 2020 2,92%
Sales 2021 26 414 M - -
Net income 2021 8 086 M - -
Net Debt 2021 19 787 M - -
P/E ratio 2021 15,8x
Yield 2021 3,12%
Capitalization 126 B 126 B -
EV / Sales 2020 5,80x
EV / Sales 2021 5,53x
Nbr of Employees 23 400
Free-Float 98,7%
More Financials
Company
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN... 
Sector
Pharmaceuticals
Calendar
11/13 | 12:35pmPresentation
More about the company
Notations Surperformance© of Amgen Inc.
Trading Rating : Investor Rating :
More Ratings
All news about AMGEN INC.
10/29Sanofi Says It Won EU Patent Ruling Against Amgen Over Cholesterol Drug -- Up..
DJ
10/29GLOBAL MARKETS LIVE: Big names today
10/29Sanofi Says It Won EU Patent Ruling Against Amgen Over Cholesterol Drug
DJ
10/29ANALYSIS : U.S. drugmakers, bracing for price cuts, shift election support towar..
RE
10/29AMGEN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
10/28AMGEN : Osteoporosis drug helps Amgen third-quarter profit beat estimates
RE
10/28AMGEN : 3Q Profits Rise on Higher Revenue; Fiscal Year Revenue Guidance Narrows
DJ
10/28AMGEN : Q3 2020 Amgen Earnings Conference Call Presentation
PU
10/28AMGEN : 3Q Earnings Snapshot
AQ
10/28AMGEN INC : Results of Operations and Financial Condition, Financial Statements ..
AQ
10/28AMGEN : Reports Third Quarter 2020 Financial Results
PR
10/28GLOBAL MARKETS LIVE : Microsoft, Deutsche Bank, SonyÖ
10/27AMGEN : Announces Webcast Of 2020 Third Quarter Financial Results
PR
10/27AMGEN : Announces Participation Of Systemic Lupus Erythematosus (SLE) Adaptive C..
PR
10/24To Find a Coronavirus Vaccine, GlaxoSmithKline Is Bonding With Its Biggest Co..
DJ
More news
News in other languages on AMGEN INC.
10/29BREVETS : Sanofi et Regeneron obtiennent gain de cause en Europe face à Amgen
10/29Sanofi et Regeneron remportent une nouvelle victoire contre Amgen sur le Pral..
10/29WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
10/29EN DIRECT DES MARCHES : LVMH, Airbus, Orange, Sanofi, Faurecia, GTT, Crédit Suis..
10/29Molecular Partners treibt Pipeline-Projekte voran
More news
Analyst Recommendations on AMGEN INC.
More recommendations
Chart AMGEN INC.
Duration : Period :
Amgen Inc. Technical Analysis Chart | AMGN | US0311621009 | MarketScreener
Technical analysis trends AMGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 251,76 $
Last Close Price 216,94 $
Spread / Highest target 40,1%
Spread / Average Target 16,1%
Spread / Lowest Target -14,7%
EPS Revisions
Managers
NameTitle
Robert A. Bradway Chairman, President & Chief Executive Officer
Esteban Santos Executive Vice President-Operations
Peter H. Griffith Chief Financial Officer
David M. Reese Executive Vice President-Research & Development
Darryl Sleep Chief Medical Officer & Senior VP-Global Medical
Sector and Competitors
1st jan.Capitalization (M$)
AMGEN INC.-10.01%126 808
JOHNSON & JOHNSON-5.95%361 159
ROCHE HOLDING AG-6.40%274 461
PFIZER INC.-9.95%196 047
MERCK & CO., INC.-16.56%191 944
NOVARTIS AG-22.62%176 518